Spex Capital
Venture capitalLondon · Seed–Series B · 1 people tracked
Investment thesis
Spex Capital is an investment firm focused on digital health and medical technology companies at the early stage. The firm invests in healthcare ventures operating across global markets.
Team · 1 people
from the firm's websiteFrequently asked questions
- What stage does Spex Capital invest at?
- Spex Capital invests at the Seed, Series A, Series B stages.
- What is Spex Capital's typical check size?
- Spex Capital typically writes checks of $635K – $2.5M.
- What sectors does Spex Capital focus on?
- Spex Capital focuses on Enterprise Software, Healthtech, Medical Devices, SaaS.
- Where is Spex Capital located?
- Spex Capital is headquartered in London, GB.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.